Tumor-feeding artery diameter reduction is associated with improved short-term effect of hepatic arterial infusion chemotherapy plus lenvatinib treatment

BACKGROUND: Recently, hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib has been frequently used to treat unresectable hepatocellular carcinoma (uHCC) in China. In the clinic, the hepatic arteries of some patients shrink significantly during this treatment, leading to improved short-term...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, De-Di, He, Xiao-Feng, Tian, Chen, Peng, Peng, Chen, Chuan-Li, Liu, Xue-Han, Pang, Hua-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331530/
https://www.ncbi.nlm.nih.gov/pubmed/36051348
http://dx.doi.org/10.3748/wjg.v28.i26.3232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331530/
https://www.ncbi.nlm.nih.gov/pubmed/36051348
http://dx.doi.org/10.3748/wjg.v28.i26.3232

Ejemplares similares